兽医抗感染药物市场－全球产业规模、份额、趋势、机会和预测，按动物类型、产品、给药途径、配销通路、地区和竞争情况细分，2020 年至 2030 年

2024 年全球兽用抗感染药物市场价值为 83.7 亿美元，预计到 2030 年将达到 122 亿美元，复合年增长率为 6.45%。随着牲畜和伴侣动物数量的持续增长，对有效疾病预防和治疗解决方案的需求不断增加，全球兽用抗感染药物市场正在稳步增长。抗感染药物在维护动物健康、确保食品安全和支持全球动物性蛋白质供应方面发挥关键作用。动物细菌、病毒和真菌感染的日益流行，使得牲畜和伴侣动物领域对先进的抗感染药物的需求日益迫切。农民和宠物主人对及时兽医护理重要性的认识不断提高，进一步加速了抗生素、抗病毒药物、抗真菌药物和联合疗法的采用。为了满足日益增长的肉类、牛奶和蛋类需求，商业化畜牧养殖的扩大更加凸显了疾病控制的重要性，兽医抗感染药物已成为现代动物保健实践中不可或缺的组成部分。

市场成长动力包括人畜共通传染病发病率的上升，这更凸显了控制动物感染以保障公众健康的重点。兽医研发投入的不断增加也推动了抗感染製剂的创新，包括长效注射剂、标靶给药系统以及解决抗药性问题的联合疗法。随着生产者和宠物主人转向降低治疗成本和提高生产力的健康管理实践，对预防性解决方案的需求日益增长。塑造市场的一个主要趋势是向益生菌、植物性和免疫刺激剂等抗生素替代品的转变，这反映了全球对抗菌素抗药性的担忧。诊断技术的不断进步也使得更快地检测感染成为可能，这补充了抗感染药物的有效使用，并支持了精准兽医用药。

市场面临的挑战可能会限制其未来几年的潜力。新兽药的高昂开发成本，加上严格的监管审批流程，往往会延迟产品的上市，并限制某些地区的可及性。对抗生素抗药性的担忧导致抗生素的使用受到更严格的限制，迫使製造商在平衡最终用户的承受能力的同时，投资替代品。小规模畜牧养殖户对正确使用抗感染药物的认知不足，可能导致药物滥用、疗效降低和抗药性风险增加。偏远或欠发达地区的供应链限制也限制了关键药物的及时取得。应对这些挑战需要政府、製药公司和兽医服务提供者之间的协调努力，以提高意识，加强分销网络，并加速更安全、可持续的抗感染解决方案的创新。儘管存在这些障碍，但全球兽用抗感染药物市场预计将在不断增长的动物健康需求、不断发展的医疗保健实践以及兽医治疗学的持续进步的支持下继续扩张。

关键市场驱动因素

畜禽传染病发生率上升

主要市场挑战

抗生素抗药性（AMR）问题日益受到关注

主要市场趋势

扩大处方管道和数位销售

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球兽用抗感染药物市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依动物类型（牲畜、伴侣动物）
  • 副产品（抗菌剂、抗真菌剂、抗病毒剂、抗寄生虫剂、其他）
  • 依给药途径（口服、注射、外用）
  • 按配销通路（医院/诊所药房、零售药房、电子商务）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美兽用抗感染药物市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲兽用抗感染药物市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区兽用抗感染药物市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美兽用抗感染药物市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲兽用抗感染药物市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Zoetis Inc.
• Boehringer Ingelheim Animal Health GmbH
• Merck & Co., Inc.
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Ceva Sante Animale SA
• Virbac SA
• Biogenesis Bago SA
• Vetoquinol SA
• Norbrook Laboratories Limited

第 16 章：策略建议

第17章调查会社について・免责事项

Global Veterinary Anti-infectives Market was valued at USD 8.37 Billion in 2024 and is expected to reach USD 12.20 Billion by 2030 with a CAGR of 6.45%. The Global Veterinary Anti-infectives Market is experiencing steady growth as livestock and companion animal populations continue to rise, driving greater demand for effective disease prevention and treatment solutions. Anti-infectives play a critical role in maintaining animal health, ensuring food safety, and supporting the global supply of animal-based proteins. The increasing prevalence of bacterial, viral, and fungal infections in animals is creating a strong need for advanced anti-infective medicines across both livestock and companion animal sectors. Growing awareness among farmers and pet owners about the importance of timely veterinary care has further accelerated the adoption of antibiotics, antivirals, antifungals, and combination therapies. Expanding commercial livestock farming to meet the rising demand for meat, milk, and eggs has amplified the importance of disease control, positioning veterinary anti-infectives as an indispensable component of modern animal healthcare practices.

Growth drivers for the market include the rising incidence of zoonotic diseases, which has heightened the focus on controlling animal infections to safeguard public health. Increasing investments in veterinary research and development are also fueling innovation in anti-infective formulations, including long-acting injectables, targeted drug delivery systems, and combination therapies that address resistance issues. Demand for preventive solutions is gaining traction as producers and pet owners shift toward health management practices that reduce treatment costs and improve productivity. A major trend shaping the market is the transition toward antibiotic alternatives such as probiotics, phytogenics, and immunostimulants, reflecting global concerns about antimicrobial resistance. Continuous advancements in diagnostic technologies are also enabling faster detection of infections, which complements the effective use of anti-infectives and supports precision veterinary medicine.

The market faces challenges that could restrict its potential in the coming years. High development costs for new veterinary medicines, coupled with stringent regulatory approval processes, often delay product launches and limit accessibility in certain regions. Concerns around antimicrobial resistance are leading to stricter restrictions on antibiotic usage, pressuring manufacturers to invest in alternatives while balancing affordability for end users. Limited awareness among small-scale livestock farmers about the correct use of anti-infectives can result in misuse, reduced efficacy, and increased resistance risks. Supply chain limitations in remote or underdeveloped areas also restrict timely access to critical medicines. Addressing these challenges requires coordinated efforts between governments, pharmaceutical companies, and veterinary service providers to enhance awareness, strengthen distribution networks, and accelerate innovation in safer, sustainable anti-infective solutions. Despite these hurdles, the Global Veterinary Anti-infectives Market is expected to expand, supported by rising animal health needs, evolving healthcare practices, and ongoing advancements in veterinary therapeutics.

Key Market Drivers

Rising Incidence of Infectious Diseases in Livestock and Poultry

The rising incidence of infectious diseases in livestock and poultry is a significant driver of the Global Veterinary Anti-infectives Market. In the United States, the USDA reported processing over 9.4 billion broiler chickens and 218 million turkeys in 2023. This large-scale production increases the risk of disease outbreaks, necessitating effective anti-infective solutions to maintain animal health and productivity. Similarly, India, with the world's highest livestock population, including 300 million cattle and buffaloes and 851 million poultry, faces challenges in managing diseases among its vast animal population. The prevalence of diseases such as Foot and Mouth Disease and Lumpy Skin Disease in these regions underscores the need for robust veterinary anti-infective measures.

In China, the Ministry of Agriculture and Rural Affairs has been proactive in enhancing animal health surveillance and disease control programs to address the growing concerns of infectious diseases in livestock and poultry. The government's efforts to strengthen veterinary infrastructure and promote disease prevention strategies have contributed to the increased demand for veterinary anti-infectives. These initiatives aim to mitigate the impact of infectious diseases on animal health and ensure food security. The escalating incidence of infectious diseases in livestock and poultry across these regions highlights the critical need for effective veterinary anti-infectives to safeguard animal health and support the growth of the global veterinary anti-infectives market.

Key Market Challenges

Rising Concerns Over Antimicrobial Resistance (AMR)

Rising concerns over antimicrobial resistance (AMR) represent one of the most significant challenges for the Global Veterinary Anti-infectives Market, as the misuse and overuse of antibiotics in livestock and companion animals contribute to the development of drug-resistant pathogens. AMR poses serious threats not only to animal health but also to human health due to the potential transfer of resistant bacteria through the food chain, direct contact, or environmental contamination. Regulatory authorities worldwide are increasingly implementing stricter guidelines to limit antibiotic use in animals, including restrictions on growth-promoting antibiotics and tighter controls on prophylactic administration. These regulations create pressure on manufacturers and veterinarians to adopt alternative approaches to disease management, such as vaccines, immunostimulants, probiotics, and other non-antibiotic therapies, which may not always be as widely available or cost-effective as traditional anti-infectives.

The growing awareness of AMR among consumers, farmers, and healthcare professionals has intensified demand for responsible and judicious use of veterinary medicines. Pharmaceutical companies face the challenge of balancing the development of effective anti-infectives with compliance to evolving global standards while ensuring affordability for farmers, particularly in emerging markets where cost sensitivity is high. Research and development efforts to create next-generation therapies that are effective yet less prone to resistance are resource-intensive, requiring significant time and financial investment. Inadequate farmer education and poor adherence to dosing protocols can exacerbate resistance issues, further complicating disease management. The AMR challenge is reshaping treatment strategies and driving innovation in veterinary medicine, but it also imposes significant operational, regulatory, and economic pressures on the veterinary anti-infectives market, making it a critical hurdle for sustained growth and adoption.

Key Market Trends

Expansion of Prescription-Based Channels and Digital Sales

A key trend in the Global Veterinary Anti-infectives Market is the expansion of prescription-based channels and digital sales, which is reshaping how veterinary medicines are accessed and distributed. Increasing regulatory oversight on antimicrobial usage, aimed at combating antimicrobial resistance, has led many countries to restrict the availability of certain anti-infective drugs over the counter, prompting a shift toward prescription-only access. This transition ensures more controlled and responsible usage of antibiotics, antivirals, and antifungal medications, while improving adherence to dosage guidelines and reducing the risk of resistance development. Prescription-based channels also allow veterinarians to play a more active role in disease management, guiding producers and pet owners on the appropriate choice of therapy and monitoring treatment outcomes.

Simultaneously, digital sales platforms and e-commerce solutions are expanding the reach of veterinary anti-infectives to both urban and rural markets. Online pharmacies and veterinary supply platforms provide convenient access to a broad portfolio of medicines, particularly for farmers managing large herds or flocks where timely procurement is essential. Integration of digital tools with prescription channels enables better tracking of drug usage, inventory management, and compliance with veterinary guidelines. Telemedicine and virtual consultation services are also gaining traction, allowing veterinarians to diagnose, prescribe, and monitor treatments remotely, which is especially valuable in regions with limited veterinary infrastructure. The combination of stricter prescription regulations and the convenience of digital sales channels is transforming the market landscape, enhancing accessibility, supporting antibiotic stewardship programs, and encouraging data-driven decision-making in veterinary healthcare. This trend is expected to continue shaping the adoption and distribution of anti-infectives across livestock and companion animal segments globally.

Key Market Players

• Zoetis Inc.
• Boehringer Ingelheim Animal Health GmbH
• Merck & Co., Inc.
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Ceva Sante Animale S.A.
• Virbac S.A.
• Biogenesis Bago S.A.
• Vetoquinol S.A.
• Norbrook Laboratories Limited

Report Scope:

In this report, the Global Veterinary Anti-infectives Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Anti-infectives Market, By Animal Type:

• Livestock Animal
• Companion Animal

Veterinary Anti-infectives Market, By Product:

• Antimicrobial
• Antifungals
• Antivirals
• Antiparasitic
• Others

Veterinary Anti-infectives Market, By Route of Administration:

• Oral
• Injectable
• Topical

Veterinary Anti-infectives Market, By Distribution Channel:

• Hospital/ Clinic Pharmacy
• Retail Pharmacies
• E-commerce

Veterinary Anti-infectives Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Anti-infectives Market.

Available Customizations:

Global Veterinary Anti-infectives Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Veterinary Anti-infectives Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Livestock Animal, Companion Animal)
  • 5.2.2. By Product (Antimicrobial, Antifungals, Antivirals, Antiparasitic, Others)
  • 5.2.3. By Route of Administration (Oral, Injectable, Topical)
  • 5.2.4. By Distribution Channel (Hospital/ Clinic Pharmacy, Retail Pharmacies, E-commerce)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Veterinary Anti-infectives Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Product
  • 6.2.3. By Route of Administration
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Anti-infectives Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Route of Administration
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Mexico Veterinary Anti-infectives Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Route of Administration
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Canada Veterinary Anti-infectives Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Route of Administration
      • 6.3.3.2.4. By Distribution Channel

7. Europe Veterinary Anti-infectives Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Product
  • 7.2.3. By Route of Administration
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Veterinary Anti-infectives Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Route of Administration
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. Germany Veterinary Anti-infectives Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Route of Administration
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Veterinary Anti-infectives Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Route of Administration
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Veterinary Anti-infectives Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Route of Administration
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Veterinary Anti-infectives Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Route of Administration
      • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Veterinary Anti-infectives Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Product
  • 8.2.3. By Route of Administration
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Veterinary Anti-infectives Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Route of Administration
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Veterinary Anti-infectives Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Route of Administration
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. South Korea Veterinary Anti-infectives Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Route of Administration
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. Japan Veterinary Anti-infectives Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Route of Administration
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Veterinary Anti-infectives Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Route of Administration
      • 8.3.5.2.4. By Distribution Channel

9. South America Veterinary Anti-infectives Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Product
  • 9.2.3. By Route of Administration
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Veterinary Anti-infectives Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Route of Administration
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. Argentina Veterinary Anti-infectives Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Route of Administration
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. Colombia Veterinary Anti-infectives Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Route of Administration
      • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Veterinary Anti-infectives Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Product
  • 10.2.3. By Route of Administration
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Veterinary Anti-infectives Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Route of Administration
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Saudi Arabia Veterinary Anti-infectives Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Route of Administration
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. UAE Veterinary Anti-infectives Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Route of Administration
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Zoetis Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Boehringer Ingelheim Animal Health GmbH
• 15.3. Merck & Co., Inc.
• 15.4. Dechra Pharmaceuticals PLC
• 15.5. Elanco Animal Health Incorporated
• 15.6. Ceva Sante Animale S.A.
• 15.7. Virbac S.A.
• 15.8. Biogenesis Bago S.A.
• 15.9. Vetoquinol S.A.
• 15.10. Norbrook Laboratories Limited

16. Strategic Recommendations

17. About Us & Disclaimer